Alexandria Venture Investments, LLC

Insider profile

Alexandria Venture Investments, LLC's trades of Intra-Cellular Therapies Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-18 2025-03-18 PrS Proposed sale
99,590
113.48
US$2,015,079
99,590 113.48 US$2,015,079
2025-03-17 2025-03-17 PrS Proposed sale
809
60.45
US$3,762,200
809 60.45 US$3,762,200
2024-09-06 2024-09-06 PrS Proposed sale
94,766
79.31
US$3,327,362
94,766 79.31 US$3,327,362
2024-06-05 2024-06-05 PrS Proposed sale
150,000
4.24
US$636,000
150,000 4.24 US$636,000
2024-06-04 2024-06-04 PrS Proposed sale
150,000
4.20
US$630,000
150,000 4.20 US$630,000
2023-12-01 2023-12-01 PrS Proposed sale
55,000
62.12
US$3,416,567
55,000 62.12 US$3,416,567
2023-11-06 2023-11-06 PrS Proposed sale
23,000
55.67
US$1,280,382
23,000 55.67 US$1,280,382
2023-11-03 2023-11-03 PrS Proposed sale
143,450
2.30
US$329,935
143,450 2.30 US$329,935
2023-11-02 2023-11-02 PrS Proposed sale
103,808
2.32
US$240,874
103,808 2.32 US$240,874
2023-11-01 2023-11-01 PrS Proposed sale
172,742
2.36
US$407,671
172,742 2.36 US$407,671
2023-10-31 2023-10-31 PrS Proposed sale
155,000
2.41
US$373,550
155,000 2.41 US$373,550
2023-09-13 2023-09-13 PrS Proposed sale
55,500
57.73
US$3,203,803
55,500 57.73 US$3,203,803
2023-08-14 2023-08-14 PrS Proposed sale
47,500
57.85
US$2,747,927
47,500 57.85 US$2,747,927
2020-09-18 2020-09-18 B Purchase
38,461 +3.0%
13.00
US$499,993
38,461 +3.0% 13.00 US$499,993
2019-07-05 2019-07-02 B Purchase
30,000 +14.0%
16.00
US$480,000
30,000 +14.0% 16.00 US$480,000
2019-05-30 2019-05-28 B Purchase
50,000 +13.1%
10.00
US$500,000
50,000 +13.1% 10.00 US$500,000